Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWAS

Overview of attention for article published in BMC Medicine, November 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 10 X users

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 38 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 11 publications that cite this research output.

11

The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.

Selection of positive controls and their impact on anti-drug antibody assay performance

Article in Journal of Immunological Methods (March 2024)

Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives

Article in Neurology and Therapy (January 2024)

Unveiling sex-based impact of TYK2 rs2304256 polymorphism on interferon beta-1alpha responsiveness in COVID-19 patients

Article in Gene Reports (December 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.